Sanofi calls €900m global media pitch

Anthisan: Sanofi brand
Anthisan: Sanofi brand

Sanofi, the French-owned pharmaceuticals giant, has launched a review of its estimated €900m global media business.

The move follows Sanofi’s acquisition of German rival Boehringer Ingelheim’s consumer drugs division last year.

Publicis Media’s Zenith is believed to handle the majority of Sanofi’s media planning and buying, while WPP’s Group M looks after some of the former Boehringer Ingelheim business.

Sanofi has appointed ID Comms, the London-based intermediary, to manage the review, which covers 60 markets, including the US and Japan. Media industry sources suggested that Sanofi has told agencies it is openminded and may not be looking to consolidate its media into a single group.

Sanofi owns brands including insect-bite cream Anthisan, diarrhoea medicine Dioralyte and conjunctivitis treatment Brochlor.

Subscribe today for just $116 a year

Get the very latest news and insight from Campaign with unrestricted access to campaignlive.com , plus get exclusive discounts to Campaign events

Become a subscriber

GET YOUR CAMPAIGN DAILY FIX

The latest work, news, advice, comment and analysis, sent to you every day

register free